Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Greece prices will fall again with harsh reimbursement list criteria

This article was originally published in Scrip

Executive Summary

The Greek government is pushing forth with negative and positive drug lists as a way to cut public pharmaceutical expenditure from about €4.3 billion for 2010 to €3.4 billion in 2011. Public pharma expenditure has fallen already significantly from the €5.1 billion in 2009, where €850 million worth of savings were made in 2010, of which €500 million were the result of drug price cuts.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts